Lv3
328 积分 2025-11-14 加入
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
3天前
已完结
Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis
3天前
已完结
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy
3天前
已完结
KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
8天前
已关闭
KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
8天前
已完结
KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity
8天前
已完结
Tumour heterogeneity and resistance to cancer therapies
19天前
已完结
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
25天前
已完结
Alternative splicing: a bridge connecting NAFLD and HCC
25天前
已完结
NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
25天前
已完结
皖公网安备34019202002308
